BPHC has announced that all CHCs with “pharmacy capacity” can now a receive a limited supply of oral antiviral pills for the outpatient treatment of mild to moderate COVID-19, through the HRSA Health Center COVID-19 Therapeutics Program.
BPHC has announced that all CHCs with “pharmacy capacity” can now a receive a limited supply of oral antiviral pills for the outpatient treatment of mild to moderate COVID-19, through the HRSA Health Center COVID-19 Therapeutics Program.